FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 90 contracts
Sources: Underwriting Agreement (Lexaria Bioscience Corp.), Underwriting Agreement (Silexion Therapeutics Corp), Underwriting Agreement (Lexaria Bioscience Corp.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇W▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇W▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 43 contracts
Sources: Underwriting Agreement (Genius Group LTD), Underwriting Agreement (Indaptus Therapeutics, Inc.), Underwriting Agreement (Enveric Biosciences, Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 21 contracts
Sources: Engagement Agreement (Oramed Pharmaceuticals Inc.), Exclusive Agency Agreement (Rexahn Pharmaceuticals, Inc.), Exclusive Agency Agreement (DelMar Pharmaceuticals, Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 18 contracts
Sources: Exclusive Agency Agreement (Rexahn Pharmaceuticals, Inc.), Exclusive Agency Agreement (Cytrx Corp), Exclusive Agency Agreement (Apricus Biosciences, Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇W▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇W▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 11 contracts
Sources: Exclusive Agency Agreement (DelMar Pharmaceuticals, Inc.), Exclusive Agency Agreement (Cancer Genetics, Inc), Exclusive Agency Agreement (CASI Pharmaceuticals, Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 6 contracts
Sources: Exclusive Agency Agreement (Oramed Pharmaceuticals Inc.), Exclusive Agency Agreement (Kitov Pharma Ltd.), Exclusive Agency Agreement (Kitov Pharma Ltd.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇R▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇▇▇▇▇R▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 6 contracts
Sources: Exclusive Agency Agreement (XTL Biopharmaceuticals LTD), Exclusive Agency Agreement (Hemispherx Biopharma Inc), Exclusive Agency Agreement (Cel Sci Corp)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇R▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇▇▇▇▇R▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 5 contracts
Sources: Exclusive Agency Agreement (Cel Sci Corp), Exclusive Agency Agreement (Cel Sci Corp), Exclusive Agency Agreement (Cel Sci Corp)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree not unreasonably withhold, condition or delay its consent to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided provided, that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 4 contracts
Sources: Exclusive Agency Agreement (Diffusion Pharmaceuticals Inc.), Exclusive Agency Agreement (Diffusion Pharmaceuticals Inc.), Exclusive Agency Agreement (Diffusion Pharmaceuticals Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇R▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇R▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 4 contracts
Sources: Exclusive Agency Agreement (Eyegate Pharmaceuticals Inc), Securities Offering Agreement (Medical Transcription Billing, Corp), Exclusive Agency Agreement (Rosetta Genomics Ltd.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇W▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇W▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 4 contracts
Sources: Exclusive Agency Agreement (Intellipharmaceutics International Inc.), Exclusive Agency Agreement (Intellipharmaceutics International Inc.), Exclusive Agency Agreement (Intellipharmaceutics International Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 3 contracts
Sources: Exclusive Agency Agreement (Medigus Ltd.), Exclusive Agency Agreement (Aethlon Medical Inc), Exclusive Agency Agreement (Cel Sci Corp)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 3 contracts
Sources: Exclusive Agency Agreement (Kitov Pharmaceuticals Holdings Ltd.), Exclusive Agency Agreement (Biostage, Inc.), Exclusive Agency Agreement (Oxis International Inc)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 3 contracts
Sources: Exclusive Agency Agreement (Bluejay Diagnostics, Inc.), Exclusive Agency Agreement (Mateon Therapeutics Inc), Exclusive Agency Agreement (Alphatec Holdings, Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall use commercially reasonable efforts to agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 2 contracts
Sources: Exclusive Agency Agreement (Oncternal Therapeutics, Inc.), Exclusive Agency Agreement (Oncternal Therapeutics, Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇W▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (( or include such revisions in the final underwriting agreement) in writing upon the request of ▇W▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 2 contracts
Sources: Underwriting Agreement (Evaxion Biotech a/S), Underwriting Agreement (Evaxion Biotech a/S)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇W▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementUnderwriting Agreement) in writing upon the request of ▇W▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract
Sources: Placement Agent Agreement (Outlook Therapeutics, Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 1 contract
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided provided, however, that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 1 contract
Sources: Exclusive Agency Agreement (RXi Pharmaceuticals Corp)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇Wainwright det▇▇▇▇▇▇▇ determines that ▇▇at any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall use commercially reasonable efforts to agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇Wainwright to ▇▇▇▇▇▇ to comply with ▇▇▇h any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Oncternal Therapeutics, Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementUnderwriting Agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract
Sources: Placement Agent Agreement (Outlook Therapeutics, Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇Wa▇▇▇▇▇▇▇▇ determines ▇etermines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇Wa▇▇▇▇▇▇▇▇ to ▇o comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇Wa▇▇▇▇▇▇▇▇ determines ▇etermines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇▇Wa▇▇▇▇▇▇▇▇ to ▇o comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 1 contract
FINRA Amendments. Notwithstanding anything herein to the the-contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementOffering Documents) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Mela Sciences, Inc. /Ny)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇R▇▇▇▇▇ or FINRA determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇▇▇▇▇R▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 1 contract
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇W▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementunderwriting) in writing upon the request of ▇W▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Ohr Pharmaceutical Inc)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇R▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇R▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 1 contract
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreementUnderwriting Agreement, if any) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement...
Appears in 1 contract
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the reasonable request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇Wa▇▇▇▇▇▇▇▇ determines ▇etermines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇Wa▇▇▇▇▇▇▇▇ to ▇o comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Intellipharmaceutics International Inc.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇W▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇W▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this AgreementCompany.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Kitov Pharmaceuticals Holdings Ltd.)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA ruleRule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇W▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇W▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected the terms set forth in this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (AmpliPhi Biosciences Corp)
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇W▇▇▇▇▇▇▇▇▇ determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the reasonable request of ▇W▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract
FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that ▇▇▇▇▇▇▇▇▇▇ reasonably determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting agreement) in writing upon the request of ▇▇▇▇▇▇▇▇▇▇ to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
Appears in 1 contract